Compound 1419
Identifiers
- Canonical SMILES:
CC(C)CN(Cc1ccc(CN(CC(C)C)S(=O)(=O)c2cc(Cl)cc(Cl)c2O)cc1)S(=O)(=O)c1cc(Cl)cc(Cl)c1O
- IUPAC name:
3,5-dichloro-N-[[4-[[(3,5-dichloro-2-hydroxyphenyl)sulfonyl-(2-methylpropyl)amino]methyl]phenyl]methyl]-2-hydroxy-N-(2-methylpropyl)benzenesulfonamide
- InChi:
InChI=1S/C28H32Cl4N2O6S2/c1-17(2)13-33(41(37,38)25-11-21(29)9-23(31)27(25)35)15-19-5-7-20(8-6-19)16-34(14-18(3)4)42(39,40)26-12-22(30)10-24(32)28(26)36/h5-12,17-18,35-36H,13-16H2,1-4H3
- InChiKey:
HAGVRVMCIASZFU-UHFFFAOYSA-N
External links
![]() 58531552 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 97 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.00 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 696.05 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 7.83 | |||
TPSA | 115.22 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 97 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.96 | |
WO2009152082 | 97 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.00 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6602 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.5203 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4932 | Evatanepag | DB12022 | |
0.4914 | Saccharin | DB12418 | |
0.4828 | Sulfabenzamide | DB09355 | |
0.4741 | Probenecid | DB01032 | |
0.4716 | Avagacestat | DB11893 | |
0.4634 | CGS-27023 | DB07556 | |
0.4595 | N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide | DB04513 | |
0.4568 | 2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | DB03207 | |
0.4516 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DB08000 | |
0.4437 | Sp-722 | DB04503 | |
0.4406 | N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DB08631 | |
0.4400 | SB-269970 | DB13988 | |
0.4384 | (3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DB07798 |